Literature DB >> 29054804

Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver.

Junichi Okada1, Shunichi Matsumoto2, Kyoichi Kaira3, Tsugumichi Saito2, Eijiro Yamada2, Hideaki Yokoo4, Ryuji Katoh5, Motoyasu Kusano6, Shuichi Okada7, Masanobu Yamada2.   

Abstract

Entities:  

Keywords:  Carcinoembryonic antigen; Cetuximab; Colon cancer; Diabetes mellitus; SGLT2 inhibitor

Mesh：

Substances：

Year:  2017        PMID： 29054804     DOI： 10.1016/j.clcc.2017.09.005

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  7 in total

1.  Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis.

Authors:  Mu-Chi Chung; Hui-Tsung Hsu; Chao-Hsiang Chang; Peir-Haur Hung; Po-Jen Hsiao; Laing-You Wu; Ming-Ju Wu; Jeng-Jer Shieh; Chi-Jung Chung
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

Review 2.  Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing.

Authors:  Talal El Zarif; Marcel Yibirin; Diana De Oliveira-Gomes; Marc Machaalani; Rashad Nawfal; Gianfranco Bittar; Hisham F Bahmad; Nizar Bitar
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

Review 3.  Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.

Authors:  Qing Ji; Qi Li; Jing Zhou
Journal:  J Exp Clin Cancer Res       Date:  2021-10-18

4.  SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Nanjing Shi; Yetan Shi; Jingsi Xu; Yuexiu Si; Tong Yang; Mengting Zhang; Derry Minyao Ng; Xiangyuan Li; Fei Xie
Journal:  Front Public Health       Date:  2021-06-07

Review 5.  Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease.

Authors:  Amr Dokmak; Mohammad Almeqdadi; Hirsh Trivedi; Sandeep Krishnan
Journal:  World J Hepatol       Date:  2019-07-27

6.  Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity.

Authors:  Junichi Okada; Eijiro Yamada; Tsugumichi Saito; Hideaki Yokoo; Aya Osaki; Yoko Shimoda; Atsushi Ozawa; Yasuyo Nakajima; Jeffrey E Pessin; Shuichi Okada; Masanobu Yamada
Journal:  Molecules       Date:  2020-01-23       Impact factor: 4.411

Review 7.  Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment - A Review.

Authors:  Kristy T K Lau; Lui Ng; Jason W H Wong; Herbert H F Loong; Wendy W L Chan; Chi Ho Lee; Carlos K H Wong
Journal:  Rev Endocr Metab Disord       Date:  2021-07-17       Impact factor: 6.514
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.